{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-005034","form_type":"8-K","ticker":"SVRA","cik":"0001160308","company_name":"Savara Inc","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.056068+00:00","generated_at":"2026-05-28T02:47:31.943365+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Savara updates corporate presentation; no material new information disclosed","bullets":["Corporate presentation updated and posted on IR website on January 13, 2025.","Presentation titled 'Developing New Therapies for Rare Respiratory Diseases'.","No specific financial data or material events provided in the filing.","Presentation furnished as Exhibit 99.1 but contains no new material substantive disclosures."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-005034","json":"https://secwatch.observer/filing/0001193125-25-005034.json","markdown":"https://secwatch.observer/filing/0001193125-25-005034.md","text":"https://secwatch.observer/filing/0001193125-25-005034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1160308/000119312525005034/0001193125-25-005034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1160308/000119312525005034/d912056d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T02:47:31.943365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}